{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T15:19:04Z","timestamp":1773242344325,"version":"3.50.1"},"reference-count":33,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2003,8,27]],"date-time":"2003-08-27T00:00:00Z","timestamp":1061942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Headache"],"published-print":{"date-parts":[[2003,9]]},"abstract":"<jats:p>Objective.\u2014To compare the efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine suppositories with sumatriptan suppositories in the treatment of 2 consecutive migraine attacks of moderate or severe intensity in a multicenter, randomized, crossover study.<\/jats:p>\n                  <jats:p>Background.\u2014A fixed combination of indomethacin, prochlorperazine, and caffeine is the most commonly used drug for the acute treatment of migraine in Italy. No studies have been published comparing the efficacy of this combination with sumatriptan, the most widely prescribed of the triptans.<\/jats:p>\n                  <jats:p>Methods.\u2014One hundred twelve patients with migraine with or without aura according to the diagnostic criteria of the International Headache Society were randomized to treat 2 migraine attacks with a fixed combination of indomethacin, prochlorperazine, and caffeine and 2 migraine attacks with sumatriptan. Both drugs were rectally administered in a single dose for each attack. Patients were asked to take study medication as soon as possible at the onset of a headache.<\/jats:p>\n                  <jats:p>\n                    Results.\u2014Of the 112 patients, 88 were compliant to the protocol. More attacks became pain\u2010free at 2 hours postdose (primary end point) on the combination than on sumatriptan (49% versus 34%;\n                    <jats:styled-content>\n                      <jats:italic>P<\/jats:italic>\n                      \u2003&lt;\u2003.01\n                    <\/jats:styled-content>\n                    ), while there was no difference in the relief of headache at 2 hours postdose (71% versus 65%). The combination was statistically superior to sumatriptan in the time to a pain\u2010free response (a higher percentage of attacks became pain\u2010free from 0.5 hours postdose to 5 hours postdose), in alleviation of nausea, and in a sustained pain\u2010free response (pain\u2010free at 2 hours postdose with no use of rescue medication or relapses within 48 hours). Moreover, a significant consistent response was achieved for the combination compared with sumatriptan across (higher percentage of patients pain\u2010free at 2 hours postdose in the first, second, third, and fourth treated attack) and within patients (pain\u2010free in 2 of 2 treated attacks in 35% of patients taking the combination and 20% of patients on sumatriptan). Both drugs were well\u2010tolerated.\n                  <\/jats:p>\n                  <jats:p>Conclusions.\u2014This study, analyzed according to the more recent guidelines for controlled trials in migraine, showed that a fixed combination of indomethacin, prochlorperazine, and caffeine is significantly more effective than sumatriptan in the acute treatment of migraine attacks. It is notable that the combination is less expensive than sumatriptan per unit dose.<\/jats:p>","DOI":"10.1046\/j.1526-4610.2003.03161.x","type":"journal-article","created":{"date-parts":[[2003,8,27]],"date-time":"2003-08-27T13:10:50Z","timestamp":1061989850000},"page":"835-844","source":"Crossref","is-referenced-by-count":31,"title":["Efficacy of a Fixed Combination of Indomethacin, Prochlorperazine, and Caffeine Versus Sumatriptan in Acute Treatment of Multiple Migraine Attacks: A Multicenter, Randomized, Crossover Trial"],"prefix":"10.1111","volume":"43","author":[{"given":"Vincenzo Di","family":"Monda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Nicolodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonina","family":"Aloisio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierluigi Del","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Fonzari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Grazioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Uslenghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Vecchiet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federigo","family":"Sicuteri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,8,27]]},"reference":[{"issue":"1","key":"e_1_2_6_2_2","first-page":"3S","article-title":"La tesi olistica dell'emicrania","volume":"12","author":"Sicuteri F","year":"1997","journal-title":"Ann Ital Med Int"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(94)90522-3"},{"key":"e_1_2_6_4_2","unstructured":"Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders cranial neuralgias and facial pain.Cephalalgia.1988;8(suppl 7):1\u201096."},{"key":"e_1_2_6_5_2","doi-asserted-by":"crossref","unstructured":"AntonaciF ParejaJA CamineroAB SjaastadO.Chronic paroxysmal hemicrania and hemicrania continua. Parenteral indomethacin: the \u201cindotest.\u201dHeadache.1998;38:122\u2010128.","DOI":"10.1046\/j.1526-4610.1998.3802122.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1998.1804225.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.1999.3910754.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2000.00073.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2000.00150.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2000.00152.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0644(94)70135-0"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0644(95)70001-3"},{"key":"e_1_2_6_13_2","unstructured":"US Headache Consortium.Evidence\u2010based guidelines for migraine headache in the primary care setting: pharmacological management of acute attacks.2000. Available at:http:\/\/www.aan.com\/public\/practiceguidelines\/03.pdf. Accessed March 5 2002."},{"key":"e_1_2_6_14_2","unstructured":"GhelardiniC GaleottiN Di Cesare MannelliL UslenghiC GrazioliI BartoliniA.Investigation into the analgesic effect of prochlorperazine.Presented in part at: the 30thAnnual Meeting Society for Neuroscience;November 2000; New Orleans La ."},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/PL00005094"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(91)90129-L"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1984.03340370043028"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06711-3"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.1998.3810748.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.1998.3810737.x"},{"key":"e_1_2_6_21_2","first-page":"377","article-title":"Equivalent efficacy of oral almotriptan, a new 5HT1B\/1D agonist, compared with sumatriptan 100 mg","volume":"38","author":"Cabarrocas X","year":"1998","journal-title":"Headache"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2000.00017.x"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.54.1.156"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91554-0"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1159\/000116757"},{"key":"e_1_2_6_26_2","doi-asserted-by":"crossref","unstructured":"International Headache Society Committee on Clinical Trials Migraine.Guidelines for controlled trials of drugs in migraine: first edition.Cephalalgia.1991;11:1\u201012.","DOI":"10.1046\/j.1468-2982.1991.1101001.x"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.2000.00117.x"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200060060-00003"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1999.00006.x"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.2000.00082.x"},{"key":"e_1_2_6_31_2","first-page":"157","volume-title":"Headache treatment, Trial Methodology, and New Drugs","author":"Tfelt\u2010Hansen P","year":"1997"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.10.1511"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.2000.00091.x"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.1998.tb11555.x"}],"container-title":["Headache: The Journal of Head and Face Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1526-4610.2003.03161.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1526-4610.2003.03161.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:20:07Z","timestamp":1762078807000},"score":1,"resource":{"primary":{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/10.1046\/j.1526-4610.2003.03161.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8,27]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["10.1046\/j.1526-4610.2003.03161.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1526-4610.2003.03161.x","archive":["Portico"],"relation":{},"ISSN":["0017-8748","1526-4610"],"issn-type":[{"value":"0017-8748","type":"print"},{"value":"1526-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,8,27]]}}}